We are seeking a dynamic Diabetes Business Consultant to drive growth and market penetration within the diabetes care sector. This role involves developing and executing strategic business plans, fostering client relationships, and ensuring the successful delivery of products and services to healthcare providers and patients.
Identify and cultivate strong relationships with key stakeholders.
Conduct thorough market research and analysis to identify new business opportunities, competitive landscapes, and emerging trends in diabetes management.
Prepare and deliver compelling sales presentations and proposals to prospective clients, effectively communicating the value proposition.
Negotiate and close business contracts, ensuring mutually beneficial agreements and long-term partnerships.
Collaborate cross-functionally with marketing, sales, and product development teams to ensure alignment of strategies and successful product launches.
Monitor and analyze sales performance, providing regular reports and forecasts to management.
Stay abreast of relevant regulatory changes and clinical advancements in diabetes care.
3–5 years of experience in doctor and specialist detailing within the KZN Province.
Working knowledge of Diabetes.
At least 3 years of experience in medical device detailing.
A nursing or allied health qualification.
Completion of the CDE course in Diabetes (noted as a distinct advantage).
Our Differences make our Performance
At Air Liquide, we are committed to build a diverse and inclusive workplace that embraces the diversity of our employees, our customers, patients, community stakeholders and cultures across the world.
We welcome and consider applications from all qualified applicants, regardless of their background. We strongly believe a diverse organization opens up opportunities for people to express their talent, both individually and collectively and it helps foster our ability to innovate by living our fundamentals, acting for our success and creating an engaging environment in a changing world.
Air Liquide is a world leader in gases, technologies and services for industry and healthcare. Present in 72 countries with 67,800 employees, the Group serves more than 4 million customers and patients. Oxygen, nitrogen and hydrogen are essential small molecules for life, matter and energy. They embody Air Liquide’s scientific territory and have been at the core of the Group’s activities since its creation in 1902.
Taking action today while preparing the future is at the heart of Air Liquide’s strategy. With ADVANCE, its strategic plan for 2025, Air Liquide is targeting a global performance, combining financial and extra-financial dimensions. Positioned on new markets, the Group benefits from major assets such as its business model combining resilience and strength, its ability to innovate and its technological expertise. The Group develops solutions contributing to climate and the energy transition—particularly with hydrogen—and takes action to progress in areas of healthcare, digital and high technologies.
Air Liquide’s revenue amounted to more than 27.5 billion euros in 2023. Air Liquide is listed on the Euronext Paris stock exchange (compartment A) and belongs to the CAC 40, CAC 40 ESG, EURO STOXX 50, FTSE4Good and DJSI Europe indexes.
